tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Atara Biotherapeutics Resubmits BLA for Tab-cel to FDA
PremiumCompany AnnouncementsAtara Biotherapeutics Resubmits BLA for Tab-cel to FDA
28d ago
Atara Biotherapeutics Holds Annual Stockholders Meeting
Premium
Company Announcements
Atara Biotherapeutics Holds Annual Stockholders Meeting
2M ago
Atara Biotherapeutics appoints Huang, Subramanian to board of directors
Premium
The Fly
Atara Biotherapeutics appoints Huang, Subramanian to board of directors
3M ago
Atara Biotherapeutics Announces Major Workforce Reduction
PremiumCompany AnnouncementsAtara Biotherapeutics Announces Major Workforce Reduction
3M ago
FDA Lifts Hold on Atara’s EBVALLO Program
Premium
Company Announcements
FDA Lifts Hold on Atara’s EBVALLO Program
3M ago
Atara Biotherapeutics: FDA lifts clinical hold on IND applications for Ebvallo
Premium
The Fly
Atara Biotherapeutics: FDA lifts clinical hold on IND applications for Ebvallo
3M ago
Atara Biotherapeutics Reports 2024 Financial Results
PremiumCompany AnnouncementsAtara Biotherapeutics Reports 2024 Financial Results
5M ago
Atara Biotherapeutics reports Q4 EPS ($1.19) vs. ($14.00) last year
Premium
The Fly
Atara Biotherapeutics reports Q4 EPS ($1.19) vs. ($14.00) last year
5M ago
ATRA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
ATRA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100